Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Fentanyl iontophoretic - ALZA Corporation

Drug Profile

Fentanyl iontophoretic - ALZA Corporation

Alternative Names: E-TRANS fentanyl; Fentanyl HCI; Fentanyl iontophoretic transdermal system; Fentanyl transdermal - ALZA Corporation; IONSYS; SyB P 1501

Latest Information Update: 31 Dec 2021

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator ALZA Corporation
  • Developer The Medicines Company
  • Class Amides; Benzene derivatives; General anaesthetics; Opioid analgesics; Piperidines; Small molecules
  • Mechanism of Action Opioid mu receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Registered Postoperative pain

Most Recent Events

  • 06 Jan 2020 The Medicines Company has been acquired by Novartis
  • 09 Feb 2018 SymBio Pharmaceuticals terminates a phase III trial for Postoperative pain due to the announcement for completion of the termination of development of SyB P-1501 in Japan (Transdermal) (NCT03005899)
  • 09 Feb 2018 Discontinued - Phase-III for Postoperative pain in Japan (Transdermal)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top